Statins and ARBs on Rheumatoid Activity
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Rheumatoid Arthritis
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 65 years
- Gender
- Both males and females
Description
The study aims at ivestigating and comparing the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients
The study aims at ivestigating and comparing the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients
Tracking Information
- NCT #
- NCT03770702
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Sahar K Hegazy, Prof Head of Clinical Pharmacy Department Study Director: Tarek M Mostafa, Prof Prof of Clinical Pharmacy Study Chair: Emad M Elshebini, MD Rheumatology Dept. - Menoufia University Study Chair: Ahmed HM El-Abd, Msc Clinical pharmacy Department-Tanta University
Get Well Soon